Viridian Pharma Ltd
2 products tracked · names used in filings: Viridian Pharma Ltd, Viridian Therapeutics Inc
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 26 Jun 2026🇺🇸 FDA approval
FDA approves Lumvoa (veligrotug-vvze), a new medicine
Viridian Therapeutics Inc; BLA761530; New biologic, Priority review; injection · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Blectifor caffeine citrate | Application withdrawn | |
| 🇺🇸 | Lumvoa veligrotug-vvze | Approved | 2026-06-26 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.